United States · Biotechnology startup
United States · Calistoga Pharmaceuticals
Calistoga Pharmaceuticals develops therapeutic oral medicines for patients suffering from cancer and inflammatory diseases.
Funding reportedLast round: Series C
Follow Calistoga Pharmaceuticals and see its new rounds in your feed.Start following
What company datasets say Calistoga Pharmaceuticals raised
Funding, as reported
Reported in all$97Min dollars
Rounds5
Last roundSeries C
Last round dateJun 2010
Investors listed7
SEC Form D$60M sold, 4 filings, last Dec 2010
Founders and team
From the SEC filings it signed: 5 on the team.
- Andrew Michael GuggenhimeExecutive Officeri
- Carol GallagherExecutive Officer, Directori
- Clifford Michael StocksExecutive Officeri
- Langdon Michael MillerExecutive Officeri
- W. Michael GallatinDirector, Promoteri
On the board, as filediEdward Michael HurwitzJames Michael TopperRichard Michael LinRobert Lee Douglas
How it ended, so far
Exit
ExitBuyerPriceWhen
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Calistoga Pharmaceuticals in front of investors. Or tell us what we have wrong.